Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patients.
Conclusions: Patient-associated features such as BMI and serum levels of TS and SHBG can improve the predictive capability of consolidate tumor-specific biomarkers in both pre- and postmenopause, thus providing a relevant contribution to the decision-making process.
PMID: 29474646 [PubMed - as supplied by publisher]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Coradini D, Orenti A, Venturelli E, Cavalleri A, Biganzoli E, Oriana S Tags: Jpn J Clin Oncol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Hormones | Men | Menopause | Obesity | Statistics | Women